ZACK ZHANG
Company: Beam Therapeutics Inc.
Job title: Director
Seminars:
Chair’s Closing Remarks 5:00 pm
day: Conference Day One
Strategies for the Analytical Development of CRISPR-Based Therapies in Rare & Ultra-Rare Diseases 1:30 pm
This workshop will explore the unique analytical development challenges and strategic considerations involved in advancing CRISPR-based therapies for rare and ultra-rare diseases. Using the recent case of the first-ever personalized CRISPR medicine as a foundation, the session will examine how analytical teams can respond to accelerated timelines, limited patient populations, and evolving regulatory expectations. Attendees…Read more
day: Pre-Conference Day
Chair’s Opening Remarks 9:20 am
day: Conference Day Two
Chair’s Closing Remarks 3:30 pm
day: Conference Day Two
Chair’s Opening Remarks 8:20 am
day: Conference Day One